Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TGTX | COMMON STOCK | Sale | -$1.45M | -75.3K | -11.53% | $19.20 | 578K | Jan 4, 2022 | Direct | F1 |
transaction | TGTX | COMMON STOCK | Sale | -$177K | -9.65K | -1.67% | $18.31 | 568K | Jan 5, 2022 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | In connection with the vesting of 160,000 shares on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. |
F2 | Includes shares of restricted Common Stock, which are subject to vesting and 140,000 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing. |